μ-Calpain Regulates Receptor Activator of NF-κB Ligand (RANKL)-supported Osteoclastogenesis via NF-κB Activation in RAW 264.7 Cells
Open Access
- 1 August 2005
- journal article
- Published by Elsevier BV in Journal of Biological Chemistry
- Vol. 280 (33), 29929-29936
- https://doi.org/10.1074/jbc.m414600200
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Got RIP?: Presenilin-dependent intramembrane proteolysis in growth factor receptor signalingCytokine & Growth Factor Reviews, 2004
- Genetic regulation of osteoclast development and functionNature Reviews Genetics, 2003
- RANK Ligand-induced Elevation of Cytosolic Ca2+ Accelerates Nuclear Translocation of Nuclear Factor κB in OsteoclastsPublished by Elsevier BV ,2003
- Histamine stimulates production of osteoclast differentiation factor/receptor activator of nuclear factor-κB ligand by osteoblastsBiochemical and Biophysical Research Communications, 2002
- Regulation of Osteoclast Differentiation by Fibroblast Growth Factor 2: Stimulation of Receptor Activator of Nuclear Factor κB Ligand/Osteoclast Differentiation Factor Expression in Osteoblasts and Inhibition of Macrophage Colony-Stimulating Factor Function in Osteoclast PrecursorsJournal of Bone and Mineral Research, 2001
- Receptor Activator of Nuclear Factor- B Ligand Activates Nuclear Factor- B in Osteoclast PrecursorsEndocrinology, 2001
- The pathogenic activation of calpain: a marker and mediator of cellular toxicity and disease statesInternational Journal of Experimental Pathology, 2000
- Bone Resorption by OsteoclastsScience, 2000
- Interleukin-1β and tumor necrosis factor-α, but not interleukin-6, stimulate osteoprotegerin ligand gene expression in human osteoblastic cellsBone, 1999
- Parathyroid Hormone Stimulates TRANCE and Inhibits Osteoprotegerin Messenger Ribonucleic Acid Expression in Murine Bone Marrow Cultures: Correlation with Osteoclast-Like Cell FormationEndocrinology, 1999